N-Nitroso Finerenone
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

N-Nitroso Finerenone

● Failure Report (NAP Test) Available

Catalogue No.:VE0014374
CAS No.:N/A
Mol. Formula:C21H21N5O4
Mol. Weight:407.43 g/mol

Additional information on N-Nitroso Finerenone

FDA Potency Category 5 NDSRI

1500 ng/day is the U.S. FDA’s current Acceptable Intake (AI) limit for N-nitroso-finerenone (NDSRI). Refer to the FDA nitrosamine page for the latest guidance.

Parent drug

Finerenone

IUPAC Name

(S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2, 8-dimethyl-1-nitroso-1, 4-dihydro-1, 6-naphthyridine-3-carboxamide

Pharmacopeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(C1=C(C)N(N=O)C2=C(C(OCC)=NC=C2C)[C@@H]1C3=CC=C(C#N)C=C3OC)N

InChI

InChI=1S/C21H21N5O4/c1-5-30-21-18-17(14-7-6-13(9-22)8-15(14)29-4)16(20(23)27)12(3)26(25-28)19(18)11(2)10-24-21/h6-8,10,17H,5H2,1-4H3,(H2,23,27)/t17-/m1/s1

Description

N-Nitroso Finerenone is an N-nitroso derivative of the secondary amine present in Finerenone which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds including those set by USP, EMA, JP, and BP. This nitroso standard is essential for a variety of applications such as analytical method development method validation (AMV) and Quality Control (QC) particularly in the context of Finerenone production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits quantify impurity levels and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

N-Nitroso Finerenone: Synthesis Attempts and Failure Report (NAP Test)

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url